6-10763079-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001242957.3(MAK):c.*1373C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.779 in 152,620 control chromosomes in the GnomAD database, including 46,366 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.78 ( 46215 hom., cov: 33)
Exomes 𝑓: 0.84 ( 151 hom. )
Consequence
MAK
NM_001242957.3 3_prime_UTR
NM_001242957.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.333
Genes affected
MAK (HGNC:6816): (male germ cell associated kinase) The product of this gene is a serine/threonine protein kinase related to kinases involved in cell cycle regulation. Studies of the mouse and rat homologs have localized the kinase to the chromosomes during meiosis in spermatogenesis, specifically to the synaptonemal complex that exists while homologous chromosomes are paired. Mutations in this gene have been associated with ciliary defects resulting in retinitis pigmentosa 62. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
TMEM14B (HGNC:21384): (transmembrane protein 14B) Enables identical protein binding activity. Involved in cerebral cortex development; neural precursor cell proliferation; and regulation of G1/S transition of mitotic cell cycle. Predicted to be integral component of membrane. Predicted to be active in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 6-10763079-G-A is Benign according to our data. Variant chr6-10763079-G-A is described in ClinVar as [Benign]. Clinvar id is 354772.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.897 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.778 AC: 118366AN: 152068Hom.: 46186 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
118366
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.841 AC: 365AN: 434Hom.: 151 Cov.: 0 AF XY: 0.865 AC XY: 225AN XY: 260 show subpopulations
GnomAD4 exome
AF:
AC:
365
AN:
434
Hom.:
Cov.:
0
AF XY:
AC XY:
225
AN XY:
260
Gnomad4 AFR exome
AC:
0
AN:
0
Gnomad4 AMR exome
AF:
AC:
2
AN:
2
Gnomad4 ASJ exome
AC:
0
AN:
0
Gnomad4 EAS exome
AC:
0
AN:
0
Gnomad4 SAS exome
AC:
0
AN:
0
Gnomad4 FIN exome
AF:
AC:
358
AN:
426
Gnomad4 NFE exome
AF:
AC:
1
AN:
2
Gnomad4 Remaining exome
AF:
AC:
4
AN:
4
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.778 AC: 118450AN: 152186Hom.: 46215 Cov.: 33 AF XY: 0.783 AC XY: 58243AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
118450
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
58243
AN XY:
74406
Gnomad4 AFR
AF:
AC:
0.754616
AN:
0.754616
Gnomad4 AMR
AF:
AC:
0.753338
AN:
0.753338
Gnomad4 ASJ
AF:
AC:
0.711982
AN:
0.711982
Gnomad4 EAS
AF:
AC:
0.91882
AN:
0.91882
Gnomad4 SAS
AF:
AC:
0.814623
AN:
0.814623
Gnomad4 FIN
AF:
AC:
0.86863
AN:
0.86863
Gnomad4 NFE
AF:
AC:
0.77539
AN:
0.77539
Gnomad4 OTH
AF:
AC:
0.76089
AN:
0.76089
Heterozygous variant carriers
0
1378
2756
4135
5513
6891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2950
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at